Feedback / Questions
NYX-2925 - Aptinyx
https://www.businesswire.com/news/home/20220407005385/en/Aptinyx-Reports-Results-from-Phase-2b-Study-of-NYX-2925-in-Painful-Diabetic-Peripheral-Neuropathy
Apr 7, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next